Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.
Senators are calling UnitedHealth Group’s response to an investigation "inadequate" and demanding more information following ...
Barchart on MSN
UnitedHealth faces renewed scrutiny into its nursing home practices. What does that mean for UNH stock?
In an election year, Washington, D.C. focused on Medicare Advantage oversight, and UnitedHealth Group (UNH) has become a ...
After a multi-year battle, the $3.3 billion acquisition of home health provider Amedisys by UnitedHealth Group’s Optum may finally go through. The Department of Justice (DOJ) has reached a proposed ...
The top brass at UnitedHealth Group offered investors a look at the company's efforts to right the ship after several rough financial quarters. CEO Stephen Hemsley said that 2026 is shaping up to be a ...
Optum on Tuesday launched the venture fund Optum Ventures, which has $250 million to invest in digital health startup companies. The venture fund will invest in companies that use data and insights to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback